Documento sobre la situación del modelo español de Medicina Intensiva. Plan estratégico SEMICYUC 2018-2022

Astigarraga, P.M. Olaechea; Saera, María Bodi; Delgado, M.C. Martín; Peña, M.S. Holanda; Mateos, A. García de Lorenzo y; Vidal, F. Gordo

doi:10.1016/j.medin.2018.04.008

Cited by 17 publications

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Intensive care professionals should consult dermatologists. We must provide comprehensive care covering any medical and surgical pathology; therefore, detection and control of different skin problems should be incorporated into routine quality care [ 74 ].…”

Section: Discussionmentioning

confidence: 99%

Dermatological Manifestations in the Intensive Care Unit: A Practical Approach

Badía

Casanova²,

Servià

et al. 2020

Critical Care Research and Practice

View full text Add to dashboard Cite

Dermatological problems are not usually related to intensive medicine because they are considered to have a low impact on the evolution of critical patients. Despite this, dermatological manifestations (DMs) are relatively frequent in critically ill patients. In rare cases, DMs will be the main diagnosis and will require intensive treatment due to acute skin failure. In contrast, DMs can be a reflection of underlying systemic diseases, and their identification may be key to their diagnosis. On other occasions, DMs are lesions that appear in the evolution of critical patients and are due to factors derived from the stay or intensive treatment. Lastly, DMs can accompany patients and must be taken into account in the comprehensive pathology management. Several factors must be considered when addressing DMs: on the one hand, the moment of appearance, morphology, location, and associated treatment and, on the other hand, aetiopathogenesis and classification of the cutaneous lesion. DMs can be classified into 4 groups: life-threatening DMs (uncommon but compromise the patient's life); DMs associated with systemic diseases where skin lesions accompany the pathology that requires admission to the intensive care unit (ICU); DMs secondary to the management of the critical patient that considers the cutaneous manifestations that appear in the evolution mainly of infectious or allergic origin; and DMs previously present in the patient and unrelated to the critical process. This review provides a characterization of DMs in ICU patients to establish a better identification and classification and to understand their interrelation with critical illnesses.

show abstract

Section: Discussionmentioning

confidence: 99%